August 02, 2026 a 09:31 am
Healthcare Stocks - Performance Analysis
The healthcare sector has shown a mixed performance across different time frames. While certain stocks have consistently outperformed, others have struggled due to various macroeconomic factors impacting the sector. This analysis aims to dissect the performances of major healthcare stocks over the past week, month, and quarter to provide a clearer perspective on potential investment strategies.
📊 Healthcare Stocks Performance One Week
Over the past week, there is a clear distinction between top performers like ISRG and ABT, whereas stocks like LLY and ABBV have significantly underperformed. Short-term market volatility and specific company news can be primary factors influencing these outcomes.
| Stock | Performance (%) | Performance |
|---|---|---|
| ISRG | 4.78 | |
| ABT | 2.61 | |
| AMGN | 2.51 | |
| TMO | 1.11 | |
| MRK | -0.66 | |
| UNH | -1.46 | |
| JNJ | -2.64 | |
| ABBV | -3.20 | |
| LLY | -3.89 |
📈 Healthcare Stocks Performance One Month
The monthly performance data highlight ABT and TMO as significant gainers, suggesting positive quarterly earnings or new product launches. ISRG has seen considerable decline, notably driven by potential market overreaction or negative news affecting its growth narrative.
| Stock | Performance (%) | Performance |
|---|---|---|
| ABT | 11.01 | |
| TMO | 9.79 | |
| AMGN | 3.16 | |
| MRK | 0.76 | |
| JNJ | -2.31 | |
| UNH | -2.38 | |
| ABBV | -3.69 | |
| LLY | -5.13 | |
| ISRG | -16.91 |
📉 Healthcare Stocks Performance Three Months
Over the three-month period, we see a robust performance from stocks like TMO, ABT, and MRK, likely driven by strong fundamental growth and positive sector trends. ISRG, however, continues to struggle, underscoring the importance of cautious evaluation for long-term investment decisions.
| Stock | Performance (%) | Performance |
|---|---|---|
| TMO | 23.08 | |
| ABT | 20.26 | |
| ABBV | 19.74 | |
| LLY | 18.43 | |
| AMGN | 18.09 | |
| MRK | 15.12 | |
| JNJ | 14.17 | |
| UNH | 11.93 | |
| ISRG | -21.92 |
💡 Summary
Despite short-term fluctuations, several healthcare companies have demonstrated substantial growth over the past three months, with TMO and ABT leading the charge. Such performances suggest resilience and growth potential within these firms. Conversely, ISRG's decline warrants a careful strategy for stakeholders, focusing on risk mitigation amid potential recovery pathways. Investors should remain vigilant of market conditions and individual stock drivers, ensuring a balanced portfolio that optimizes returns while minimizing exposure to downturns.
Smart Data Insight
Master the Perfect Entry & Exit for this Stock
Don't leave your profits to chance. Historically, this stock follows specific seasonal patterns that institutional traders use to maximize returns.
- ✅ Identify the "Golden Buying Window"
- ✅ Avoid high-risk correction cycles
- ✅ Backtested data from the last 20+ years